中文名称 |
Isoquercitrin;Isoquercetin; Isoquercitroside
|
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
中文别名 |
异槲皮苷;异槲皮甙;槲皮素-3-葡萄糖甙;槲皮素-3-呋喃葡糖苷;2,9-二苯基-1,10-菲咯啉;Isoquercitrin 异槲皮苷 标准品;槲皮素-3'-O-葡萄糖苷;槲皮素-3-O-葡萄糖苷;槲皮素-3-O-葡萄糖苷,Isoquercitrin,植物提取物,标准品,对照品;槲皮素-3-氧葡萄糖甙;异槲皮苷 EP标准品;异槲皮苷 异栎素 Isoquercitrin;异槲皮苷(标准品);异槲皮苷(异槲皮素);异槲皮苷对照品;柚皮素-7-O-葡萄糖苷;分析对照品;槲皮素-3-β-D-葡萄糖苷;罗布麻甲素;异槲皮甙,异栎素,槲皮素-3-葡萄糖甙;异槲皮素;异栎素
|
||||||||||||
英文名称 |
Isoquercitrin;Isoquercetin; Isoquercitroside
|
||||||||||||
英文别名 |
2-(3,4-dihydroxyphenyl)-3-(β-D-glucofuranosyloxy)-5,7-dihydroxy-4H-1-benzopyran-4-one;4H-1-Benzopyran-4-one,2-(3,4-dihydroxyphenyl)-3-(b-D-glucofuranosyloxy)-5,7-dihydroxy-;Isoquercitrin;Isoquercitroside;2-(3,4-dihydroxyphenyl)-3-(βIsopseudopsoralen;isopseudopsoralene;isopseudosporalen;Isoquercetin;quercetin 3-O-beta-D-glucofuranoside;Quercetin 3-O-glucofuranoside;quercetin 3-O-glucoside;Quercetin 3-β-D-glucoside;quercetin-3-glucoside;Quercetin 3-beta-D-glucoside;2-(3,4-Hihydroxyphenyl)-3-(beta-D-glucofuranosyloxy)-5,7-dihydroxy-4H-1-benzopyran-4-one;2-(3,4-dihydroxyphenyl)-3-(β-D-glucofuranosyloxy)-5,7-dihydroxy-4H-1-benzopyran-4-one;Isoquercitrin with HPLC [21637-25-2]
|
||||||||||||
Cas No. |
21637-25-2
|
||||||||||||
分子式 |
C21H20O12
|
||||||||||||
分子量 |
464.38
|
||||||||||||
包装储存 |
|
生物活性 |
Isoquercitrin (Isoquercitroside) is an effective antioxidant and an eosinophilic inflammation suppressor. |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
性状 |
Solid |
||||||||||||
体外研究(In Vitro) |
Isoquercitrin occurs widely in plants.10 μM of Isoquercitrin of the seven compounds partially but significantly blunt the negative effect of H2O2 on RGC-5 cells, as the viability of cells in the presence of H2O2 is increased from approximately 63% to 83% and 90% at 10 and 50 μM, respectively. Indeed, 50 μM Isoquercitrin is more effective as a neuroprotectant than the same concentration of EGCG. Medlife has not independently confirmed the accuracy of these methods. They are for reference only. |
||||||||||||
体内研究(In Vivo) |
In animals receiving Isoquercitrin, eosinophil counts are lower in the BALF, blood and lung parenchyma. Neutrophil counts in blood and IL-5 levels in lung homogenate are lower only in Isoquercitrin-treated mice. No alterations in mononuclear cell numbers were observed. Medlife has not independently confirmed the accuracy of these methods. They are for reference only. |
||||||||||||
运输条件 |
Room temperature or refrigerated transportation. |
||||||||||||
储存方式 |
|
||||||||||||
结构分类 | |||||||||||||
来源 | |||||||||||||
参考文献 |
|
溶解度数据 |
体外研究:
DMSO : 125 mg/mL (269.18 mM; Need ultrasonic) 配制储备溶液
*
产品不同,其溶解度不同。建议根据产品选择合适的溶剂配制储备溶液;配成溶液后,建议分装保存,避免反复冻融造成的产品失效。 体内研究:
建议根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都建议先按照 体外研究 方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
*
|
---|
1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。
2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。
Copyright © 2025 陌孚医药 All rights reserved 未经授权禁止拷贝本站所有资料,如有违反,将追究法律责任。
沪ICP备2023012080号 |
沪公网安备31011402010657号